Source: International Congress 2019 – Lung transplantation: from bench to bedside
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Piloni (Pavia, Italy), E. Gabanti (Pavia, Italy), M. Morosini (Pavia, Italy), T. Oggionni (Pavia, Italy), L. Saracino (Pavia, Italy), V. Conio (Pavia, Italy), D. Lilleri (Pavia, Italy), F. Meloni (Pavia, Italy). Effective prevention of human cytomegalovirus (HCMV) disease in lung transplant recipients (LTR) by pre-emptive therapy based on HCMV monitoring in blood and lung. 1102

Member's Comments

No comment yet.

Related content which might interest you: Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 CMV management in lung transplant recipients Source: School Course 2012 - Lung Transplantation Year: 2012 Increased LIR-1 expression precedes serum cytomegalovirus detection and diagnosis of CMV disease in lung transplant recipients Source: Eur Respir J 2002; 20: Suppl. 38, 347s Year: 2002 Prolonged oral ganciclovir (GCV) reduces the incidence of CMV infection and disease after lung transplantation (LTx) Source: Eur Respir J 2006; 28: Suppl. 50, 777s Year: 2006 Cytomegalovirus infection in lung transplant patients: the role of prophylaxis and recipient-donor serotype matching Source: Eur Respir J 2005; 26: Suppl. 49, 636s Year: 2005 Epidemiology of community acquired viral respiratory infections in a cohort of lung transplant recipients (LTR) Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 The frequency of cytomegalovirus infection detecting of patients with lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 153s Year: 2006 Human lung transplantation: cytomegaloviral and rhinoviral co-infection is a distinct risk for acute rejection Source: Annual Congress 2009 - Human and experimental lung transplantation: novel findings Year: 2009 Combined CMV prophylaxis reduces short term complications after lung transplantation Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients Year: 2012 The role of cytomegalovirus infection in the course of the lung diseases in children Source: Eur Respir J 2005; 26: Suppl. 49, 643s Year: 2005 Cytomegalovirus quantitative-PCR study in pulmonary tissue from lung transplant recipients Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 EBV and CMV as possible pathogens in patients presenting with interstitial lung disease Source: Eur Respir J 2006; 28: Suppl. 50, 154s Year: 2006 A single-season prospective study of respiratory viral infections in lung transplant recipients Source: Eur Respir J 2006; 28: 131-137 Year: 2006 Longitudinal assessment of CD4+CD25highCD69- treg cells in a cohort of lung transplant recipients (LTR). An association with chronic graft rejection Source: Annual Congress 2008 - Donor organs and complications after lung transplantation Year: 2008 Diagnosis of latent tuberculosis infection in patients with chronic liver disease undergoing liver transplantation: performance of the new IFN-γ-based assays Source: Eur Respir J 2007; 30: Suppl. 51, 752s Year: 2007 Pulmonary cytomegalovirus infections following renal transplantation Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 Cytomegalovirus (CMV) damage of the lungs associated with pulmonary tumours: is it a fortuitousness or a rule? Source: Eur Respir J 2003; 22: Suppl. 45, 249s Year: 2003 Specificities of the paediatric lung transplant recipient Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients Year: 2005 Incidence of viral infections in patients with lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Cytomegalovirus (CMV) infection – Correlation between CMV-DNA PCR in bronchoalveolar lavage (BAL), CMV pp65 antigen load in PBMCs and clinical symptoms in lung transplant recipients Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011